175 related articles for article (PubMed ID: 38002248)
21. Antinuclear antibodies in healthy aging people: a prospective study.
Xavier RM; Yamauchi Y; Nakamura M; Tanigawa Y; Ishikura H; Tsunematsu T; Kobayashi S
Mech Ageing Dev; 1995 Mar; 78(2):145-54. PubMed ID: 7596195
[TBL] [Abstract][Full Text] [Related]
22. Expanded assessment of xenobiotic associations with antinuclear antibodies in the United States, 1988-2012.
Dinse GE; Co CA; Parks CG; Weinberg CR; Xie G; Chan EKL; Birnbaum LS; Miller FW
Environ Int; 2022 Aug; 166():107376. PubMed ID: 35785669
[TBL] [Abstract][Full Text] [Related]
23. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in the association between antinuclear antibody positivity with diabetes and multimorbidity in older adults: Results from the Baltimore Longitudinal Study of Aging.
Meier HCS; Sandler DP; Simonsick EM; Weng NP; Parks CG
Exp Gerontol; 2020 Jul; 135():110906. PubMed ID: 32145292
[TBL] [Abstract][Full Text] [Related]
25. Antinuclear antibodies and bromoxynil exposure in a rural sample.
Semchuk KM; Rosenberg AM; McDuffie HH; Cessna AJ; Pahwa P; Irvine DG
J Toxicol Environ Health A; 2007 Apr; 70(7):638-57. PubMed ID: 17365618
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
27. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
Duran A; Çetin Duran A; Taşkıran İ
Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: A single center study.
Lang J; Ma K; Guo J; Zhang J; Wang Q; Sun H
J Cancer Res Ther; 2018 Jan; 14(1):213-219. PubMed ID: 29516988
[TBL] [Abstract][Full Text] [Related]
29. High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA).
Seelig CA; Blüthner M; Seelig HP
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390377
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
31. The Clinical Relevance of Anti-DFS70 Autoantibodies.
Conrad K; Röber N; Andrade LE; Mahler M
Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
[TBL] [Abstract][Full Text] [Related]
32. ANA-specific antibodies, ANA patterns, anti-ds-DNA results, and clinical diagnosis: a laboratory and clinical audit.
Anis S; Fatima A; Abdul Jabbar S; Arain T
Immunol Res; 2023 Apr; 71(2):267-275. PubMed ID: 36456720
[TBL] [Abstract][Full Text] [Related]
33. Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses.
Cuomo L; Cirone M; Di Gregorio AO; Vitillo M; Cattivelli M; Magliocca V; Maiorano S; Meledandri M; Scagnolari C; La Rocca S; Trivedi P
Virus Res; 2015 Jan; 195():95-9. PubMed ID: 25300805
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort.
Martinez-Revuelta D; Irure-Ventura J; López-Hoyos M; Olmos JM; Pariente E; Martín-Millán M; Nan D; Comins-Boo A; Martínez-Taboada VM; Hernández JL
Clin Chem Lab Med; 2023 May; 61(6):1095-1104. PubMed ID: 36634098
[TBL] [Abstract][Full Text] [Related]
35. Hygiene Hypothesis Indicators and Prevalence of Antinuclear Antibodies in US Adolescents.
Meier HCS; Sandler DP; Wilkerson J; Miller FW; Dinse GE; Parks CG
Front Immunol; 2022; 13():789379. PubMed ID: 35154106
[TBL] [Abstract][Full Text] [Related]
36. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
37. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
Al-Mughales JA
Front Immunol; 2022; 13():850759. PubMed ID: 35359932
[TBL] [Abstract][Full Text] [Related]
38. Sex-Specific Associations Between Serum Lipids, Antinuclear Antibodies, and Statin Use in National Health and Nutrition Examination Surveys 1999-2004.
Andersen CJ; Vance TM
Front Med (Lausanne); 2022; 9():887741. PubMed ID: 35721098
[TBL] [Abstract][Full Text] [Related]
39. Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.
Parks CG; Miller FW; Satoh M; Chan EK; Andrushchenko Z; Birnbaum LS; Jusko TA; Kissling GE; Patel MD; Rose KM; Weinberg C; Zeldin DC; Sandler DP
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2492-502. PubMed ID: 25086100
[TBL] [Abstract][Full Text] [Related]
40. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
